Doctors warn of an "enormous" risk of overdose after testing of a popular unapproved weight loss peptide reveals the product had double the strength of what was listed on its label.

Compounding of this drug is currently illegal under federal law in the U.S. However, buzz around the drug’s effectiveness has led many people to seek it out online from companies or platforms that ...

Megan Hancocks bought a drug labelled as the peptide compound retatrutide in cash from a beautician. Within a week of her second dose, she was in acute liver failure.

Medics have issued an urgent warning around an experimental weight loss medication which is currently undergoing clinical ...

Eli Lilly has now issued a stark warning about the "counterfeit" and "black market" versions already being sold online ...

Retatrutide isn't supposed to be everywhere. Touted as the next generation in the GLP-1 craze, it's an experimental weight-loss drug that is not authorized outside of clinical trials. The Food and ...

Retatrutide weight loss drug trials recorded 28.3% average body weight loss, outpacing surgery and all existing GLP-1 medications. The post Dr. Dubrow Calls Retatrutide the Most Powerful Weight-Loss ...

Retatrutide is a triple agonist, meaning it targets three hormone receptor agonists: GLP-1, GIP and glucagon (GCG). It’s ...

This was exactly what I wanted, but I wanted this over three months. But every time I looked in the mirror, my body was changing more and more.” She liked how she looked. “Especially as a woman, so ...

The next generation of glucagonlike peptide 1 (GLP-1) weight-loss drugs has taken another step forward to U.S. Food and Drug Administration approval. In new clinical trial results from the ...

Clinical trials for Retatrutide, considered the final boss of injectable weight loss medication, are ongoing ...